Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.4, replacing the previous v3.5.3, indicating a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-05-15T16:02:11.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    A footer release/version update was applied on the study page (updating the visible “Revision” number from v3.5.2 to v3.5.3). This reflects a site change rather than an alteration to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T06:22:31.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:04.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added revision entry v3.5.0 and removed revision entry v3.4.3, affecting only the page's release metadata.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:24.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:30.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and Revision: v3.4.1 removed; the government funding/operating status notice was deleted.
    Difference
    0.4%
    Check dated 2026-02-11T11:38:28.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.